Wotton Paul K
Director at VCEL; President and CEO at ANTARES PHARMA, INC.
- Sold, on record
- $4.3M
- Dollars the filings state
- Form 4 sales
- 18
- Latest May 11, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- VCELVericel CorpDirector
- ANTARES PHARMA, INC.President and CEO
Sales by reason
0
Routine
10
Plan not stated
3
No plan
5
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ANTARES PHARMA, INC.412,000 shares
- VCEL95,748 shares
Shares sold, every Form 4 sale on record.
Timeline
- May 11, 2026Unusual
Sold 34.7% of their holdings
$327k10,000 shares at $32.74
- May 11, 2026Notice
Filed a notice to sell 10,000 shares
$327k10,000 shares
- Dec 3, 2025No plan
Sold 16.3% of their holdings
$190k5,000 shares at $37.90
- Dec 3, 2025Notice
Filed a notice to sell 2,500 shares
$95k2,500 shares
- Dec 2, 2025Notice
Filed a notice to sell 2,500 shares
$95k2,500 shares
- Dec 4, 2024No plan
Sold 8.7% of their holdings
$153k2,600 shares at $58.72
- Dec 4, 2024Notice
Filed a notice to sell 2,600 shares
$218k2,600 shares
- Dec 14, 2023No plan
Sold 15.7% of their holdings
$187k5,000 shares at $37.31
- Dec 14, 2023Notice
Filed a notice to sell 5,000 shares
$185k5,000 shares
- May 14, 2021Plan not stated
Sold 15.8% of their holdings
$253k5,000 shares at $50.52
10 of 23
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13, 2026 | VCEL | Director | Form 4 sale | 10,000 | $327k | 34.7% | Unusual | SEC |
| May 11, 2026 | May 11, 2026 | VCEL | Director | Form 144 notice | 10,000 | $327k | Notice | SEC | |
| Dec 3, 2025 | Dec 4, 2025 | VCEL | Director | Form 4 sale | 5,000 | $190k | 16.3% | No plan | SEC |
| Dec 3, 2025 | Dec 3, 2025 | VCEL | Director | Form 144 notice | 2,500 | $95k | Notice | SEC | |
| Dec 2, 2025 | Dec 2, 2025 | VCEL | Director | Form 144 notice | 2,500 | $95k | Notice | SEC | |
| Dec 4, 2024 | Dec 5, 2024 | VCEL | Director | Form 4 sale | 2,600 | $153k | 8.7% | No plan | SEC |
| Dec 4, 2024 | Dec 4, 2024 | VCEL | Director | Form 144 notice | 2,600 | $218k | Notice | SEC | |
| Dec 14, 2023 | Dec 15, 2023 | VCEL | Director | Form 4 sale | 5,000 | $187k | 15.7% | No plan | SEC |
| Dec 14, 2023 | Dec 14, 2023 | VCEL | Director | Form 144 notice | 5,000 | $185k | Notice | SEC | |
| May 14, 2021 | May 17, 2021 | VCEL | Director | Form 4 sale | 5,000 | $253k | 15.8% | Plan not stated | SEC |
| May 12, 2021 | May 13, 2021 | VCEL | Director | Form 4 sale | 15,648 | $781k | 33.1% | Unusual | SEC |
| Jan 2, 2019 | Jan 4, 2019 | VCEL | Director | Form 4 sale | 22,500 | $379k | 100.0% | Unusual | SEC |
| Jun 18, 2018 | Jun 20, 2018 | VCEL | Director | Form 4 sale | 30,000 | $362k | 100.0% | Unusual | SEC |
| Jan 15, 2014 | Jan 17, 2014 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 22,900 | $117k | 3.1% | Plan not stated | SEC |
| Dec 9, 2013 | Dec 10, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 64,100 | $256k | 8.3% | Plan not stated | SEC |
| Oct 1, 2013 | Oct 3, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 35,000 | $147k | 4.7% | Plan not stated | SEC |
| Sep 3, 2013 | Sep 5, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 35,000 | $154k | 4.7% | Plan not stated | SEC |
| Aug 1, 2013 | Aug 5, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 35,000 | $155k | 4.7% | Plan not stated | SEC |
| Jul 1, 2013 | Jul 3, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 35,000 | $145k | 4.7% | Plan not stated | SEC |
| Jun 3, 2013 | Jun 5, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 125,000 | $501k | 15.0% | Unusual | SEC |
| May 6, 2013 | May 8, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 10,000 | $40k | 1.9% | Plan not stated | SEC |
| Jan 8, 2013 | Jan 10, 2013 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 25,000 | $100k | 4.4% | Plan not stated | SEC |
| Dec 4, 2012 | Dec 6, 2012 | ANTARES PHARMA, INC. | President and CEO | Form 4 sale | 25,000 | $100k | 4.4% | Plan not stated | SEC |